FUJIFILM Holdings

Message from Leadership

[image]Kenji Sukeno : Chairman, Representative Director & Board Chairman (left) Teiichi Goto : President, Representative Director & Chief Executive Officer (right)

Kenji Sukeno : Chairman, Representative Director & Board Chairman (left)
Teiichi Goto : President, Representative Director & Chief Executive Officer (right)

FUJIFILM Holdings is a holding company with two operating companies—FUJIFILM Corporation and FUJIFILM Business Innovation Corporation.

Fujifilm Group is developing its global business with the overarching goal of creating a healthier and more sustainable world. To further the realization of a decarbonized society, the Group has targeted net zero CO2 emissions from our energy consumption by the Fiscal Year ending March 2041 (FY2040). We have also targeted 50% reduction of CO2 emissions across the entire product life cycle by FY2030, as compared to the FY2019 level. To achieve this target, we launched a new environmental strategy, “Green Value Climate Strategy,” which includes “Green Value Manufacturing”—a strategy to manufacture with a lower environmental impact, and delivering “Green Value Products” with excellent environmental performance.

Fujifilm Group is also focusing on creating products and services that support the digital transformation (DX) which is revolutionizing our society and business systems, making full use of digital technologies such as artificial intelligence (AI). We are making efforts to actualize sustainable innovation across the group, enhancing innovative technologies and creating new business value.

In our highly focused Healthcare segment, we provide cutting-edge products and services that address unmet medical needs, improve access to medical care, and detect diseases in their early stages. In our medical diagnostic equipment business, we are creating new value by incorporating the most advanced image processing technology, AI technology, and other proprietary technologies into our extensive product lineup of CT, MRI, X-ray, ultrasound, and endoscopy systems. Furthermore, our Contract Development and Manufacturing Organization (CDMO) business for biologics is facilitating a stable supply of high-quality biopharmaceuticals and promoting process development and contract manufacturing of gene therapy drugs, a field of advanced medical treatment.

The world faces many challenges, and Fujifilm Group will NEVER STOP taking them on, developing innovative products and services with advanced, proprietary technologies, as we strive to build a more sustainable society.

Kenji Sukeno
Chairman, Representative Director & Board Chairman

Teiichi Goto
President, Representative Director & Chief Executive Officer

[image]Special Contents & Movies
Special Contents & Movies

Introducing past movies of our president, Teiichi Goto.